Physician profile
Gregory E Huff
NPI 1730156241
$1,067.33
in general payments reported to CMS, 2019-2025
17 companies · $83.55 in 2025
The $83.55 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $82.99 · 2021: $174 · 2022: $272 · 2023: $177 · 2024: $107 · 2025: $83.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $189.16 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $144.93 | 2021-2023 | |
| Abbvie INC. | $116.91 | 2022-2025 | |
| Pfizer INC. | $100.17 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.59 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $68.60 | 2019-2021 | |
| La Jolla Pharmaceutical Company | $66.01 | 2019-2023 | Xerava |
| Novo Nordisk INC | $55.64 | 2020-2023 | |
| Boston Scientific Corporation | $40.09 | 2023-2024 | Watchman Flx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.30 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $32.77 | 2019-2022 | |
| Stryker Corporation | $31.14 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tetraphase Pharmaceuticals, INC. | $24.43 | 2020 | |
| Paratek Pharmaceuticals, INC. | $22.96 | 2025 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $22.43 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12.99 | 2019 | |
| Portola Pharmaceuticals, LLC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.